Literature DB >> 15215158

Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span.

Riccardo E Nisato1, Jillian A Harrison, Raphaele Buser, Lelio Orci, Chris Rinsch, Roberto Montesano, Philippe Dupraz, Michael S Pepper.   

Abstract

The study of lymphatic endothelial cells and lymphangiogenesis has, in the past, been hampered by the lack of lymphatic endothelial-specific markers. The recent discovery of several such markers has permitted the isolation of lymphatic endothelial cells (LECs) from human skin. However, cell numbers are limited and purity is variable with the different isolation procedures. To overcome these problems, we have transfected human dermal microvascular endothelial cells (HDMVECs) with a retrovirus containing the coding region of human telomerase reverse transcriptase (hTERT), and have produced a cell line, hTERT-HDLEC, with an extended lifespan. hTERT-HDLEC exhibit a typical cobblestone morphology when grown in culture, are contact-inhibited, and express endothelial cell-specific markers. hTERT-HDLEC also express the recognized lymphatic markers, Prox-1, LYVE-1 and podoplanin, as well as integrin alpha9, but do not express CD34. They also form tube-like structures in three-dimensional collagen gels when stimulated with vascular endothelial growth factors -A and -C. Based on these currently recognized criteria, these cells are LEC. Surprisingly, we also found that the widely studied HMEC-1 cell line expresses recognized lymphatic markers; however, these cells are also CD34-positive. In summary, the ectopic expression of hTERT increases the life span of LECs and does not affect their capacity to form tube-like structures in a collagen matrix. The production and characterization of hTERT-HDLEC will facilitate the study of the properties of lymphatic endothelium in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215158      PMCID: PMC1618539          DOI: 10.1016/S0002-9440(10)63271-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.

Authors:  T M Kinsella; G P Nolan
Journal:  Hum Gene Ther       Date:  1996-08-01       Impact factor: 5.695

2.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

3.  E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis.

Authors:  B Engelhardt; D Vestweber; R Hallmann; M Schulz
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

4.  Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).

Authors:  M G Achen; M Jeltsch; E Kukk; T Mäkinen; A Vitali; A F Wilks; K Alitalo; S A Stacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

5.  A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.

Authors:  V Joukov; V Kumar; T Sorsa; E Arighi; H Weich; O Saksela; K Alitalo
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

6.  Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.

Authors:  Z Zhu; P Rockwell; D Lu; H Kotanides; B Pytowski; D J Hicklin; P Bohlen; L Witte
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

7.  Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.

Authors:  Satoshi Hirakawa; Young-Kwon Hong; Natasha Harvey; Vivien Schacht; Kant Matsuda; Towia Libermann; Michael Detmar
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

8.  CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.

Authors:  A W Griffioen; M J Coenen; C A Damen; S M Hellwig; D H van Weering; W Vooys; G H Blijham; G Groenewegen
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

9.  Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.

Authors:  M S Pepper; S J Mandriota
Journal:  Exp Cell Res       Date:  1998-06-15       Impact factor: 3.905

10.  Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31).

Authors:  M Litwin; K Clark; L Noack; J Furze; M Berndt; S Albelda; M Vadas; J Gamble
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  38 in total

Review 1.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

2.  Non-peptide small molecule regulators of lymphangiogenesis.

Authors:  Changge Fang; Marta Aparicio Miguel; Ingalill Avis; Alfredo Martinez; Enrique Zudaire; Frank Cuttitta
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

Review 3.  Lymphangiogenesis: a new player in cancer progression.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Omar M Rashid; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

4.  Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis.

Authors:  Signe Ingvarsen; Astrid Porse; Charlotte Erpicum; Ludovic Maertens; Henrik J Jürgensen; Daniel H Madsen; Maria C Melander; Henrik Gårdsvoll; Gunilla Høyer-Hansen; Agnès Noel; Kenn Holmbeck; Lars H Engelholm; Niels Behrendt
Journal:  J Biol Chem       Date:  2013-02-14       Impact factor: 5.157

5.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Authors:  Michael J Flister; Andrew Wilber; Kelly L Hall; Caname Iwata; Kohei Miyazono; Riccardo E Nisato; Michael S Pepper; David C Zawieja; Sophia Ran
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

6.  Attenuated Joint Tissue Damage Associated With Improved Synovial Lymphatic Function Following Treatment With Bortezomib in a Mouse Model of Experimental Posttraumatic Osteoarthritis.

Authors:  Wensheng Wang; Xi Lin; Hao Xu; Wen Sun; Echoe M Bouta; Michael J Zuscik; Di Chen; Edward M Schwarz; Lianping Xing
Journal:  Arthritis Rheumatol       Date:  2019-01-05       Impact factor: 10.995

7.  A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Authors:  Sabreena Safuan; Sarah J Storr; Poulam M Patel; Stewart G Martin
Journal:  Lymphat Res Biol       Date:  2012-12-05       Impact factor: 2.589

8.  Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.

Authors:  Megan E Spurgeon; Johan A den Boon; Mark Horswill; Sonalee Barthakur; Omid Forouzan; Janet S Rader; David J Beebe; Avtar Roopra; Paul Ahlquist; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

9.  Establishment and characterization of Fabry disease endothelial cells with an extended lifespan.

Authors:  Jin-Song Shen; Xing-Li Meng; Raphael Schiffmann; Roscoe O Brady; Christine R Kaneski
Journal:  Mol Genet Metab       Date:  2007-07-17       Impact factor: 4.797

10.  Functional and gene expression analysis of hTERT overexpressed endothelial cells.

Authors:  Haruna Takano; Satoshi Murasawa; Takayuki Asahara
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.